Known as the "next-generation weight management probiotic strain," high-activity Akkermansia muciniphila has garnered global attention for its ability to regulate gut microbiota, promote metabolic balance, and address obesity-related health concerns. Today, Wecare has achieved industrial-scale production of this cutting-edge "weight management probiotic" in China, with an impressive annual Raw Material production capacity of 200 tons, marking a significant milestone in the global probiotics industry.
 
With its extensive expertise in probiotics and advanced technologies, Wecare has emerged as a leading manufacturer of a newly discovered, proprietary gram-negative Akkermansia muciniphila, from laboratory development to pilot trials and full-scale industrial production.

By utilizing advanced fermentation techniques, downstream processing, and quality control measures, Akkermansia muciniphila maintains outstanding activity and stability. These processes ensure that the probiotic retains its efficacy throughout transportation, storage, and application. 

Production Capabilities:
This industrialization breakthrough not only sets a new benchmark for production capacity but also reaches an impressive 600 billion AFU/g with Live Probiotic Strain and 1 trillion TFU/g withHeat-Killed Strain（Inactive）.

Product Specifications:

•Live Probiotic Powder: 200 billion AFU/g, and 400 billion AFU/g;
•Inactive Probiotic Powder: 200 billion, 400 billion, and 600 billion TFU/g.
 
Wecare's success in pioneering industrial-scale production of Akkermansia muciniphila highlights its dedication to advancing microbiome science and addressing the growing demand for innovative probiotic solutions. With its deep expertise and robust infrastructure, Wecare continues to set new standards in the probiotics industry, fostering a future of enhanced health and wellness.